tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ashwani Verma, 53 are a BUY (77.94%), 12 are a HOLD (17.65%), 3 are a SELL (4.41%).
Analyst Ashwani Verma, currently employed at UBS, carries an average stock price target met ratio of 61.48% that have a potential upside of 23.8% achieved within 151 days.
Ashwani Verma’s has documented 136 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 23-Jan-2025.
Analyst best performing recommendations are on ACLX (ARCELLX).
The best stock recommendation documented was for ACLX (ARCELLX) at 10/17/2023. The price target of $52 was fulfilled within 30 days with a profit of $16.84 (47.9%) receiving and performance score of 15.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$132
$4.18 (3.27%)
$113
15 days ago
(31-Jan-2025)
12/13 (92.31%)
$5 (3.94%)
737
Buy
$132
$4.18 (3.27%)
$28
15 days ago
(31-Jan-2025)
4/5 (80%)
$5 (3.94%)
897
Buy
$132
$4.18 (3.27%)
$108
24 days ago
(22-Jan-2025)
21/22 (95.45%)
$5.5 (4.35%)
244
Buy
$100
$-27.82 (-21.76%)
$100
1 months 2 days ago
(13-Jan-2025)
24/25 (96%)
$-27.71 (-21.70%)
165
Buy
$89
$-38.82 (-30.37%)
$81
3 months 11 days ago
(04-Nov-2024)
9/9 (100%)
$2.02 (2.32%)
43
Which stock is Ashwani Verma is most bullish on?
Which stock is Ashwani Verma is most reserved on?
What Year was the first public recommendation made by Ashwani Verma?
